NEW YORK, Sept. 18, 2018 /PRNewswire/ -- Some of the most exciting talks at Ascent Conference 2018 - www.ascentconf.com - October 3-4, include FCC Commissioner Mignon Clyburn on net neutrality, Cloud Foundry's Abby Kearns insight into the cloud native future, and much more! See the full agenda, with Startup Stage and Round Tables: www.ascentconf.com/agenda
Agenda Sneak Peek:
Ryan Howard, MLB All Star & Venture Capitalist @ SeventySix Capital
Kenneth Lin, Founder & CEO @ Credit Karma
Luis von Ahn, Co-Founder & CEO @ Duolingo
Mignon Clyburn, FCC Commissioner
Samantha Scharff, CEO @ Future 8 (fmr. CEO @ GIPHY Studios)
Dennis Crowley, Co-Founder & Executive Chairman @ Foursquare
Ascent is a 2 day Conference focused on bringing together senior leaders in the East Coast Tech community to learn, collaborate, and build the relationships needed to drive meaningful change. We've curated an experience that the industry needs, focused on education and networking that will help accelerate innovation.
VIAVI Solutions ("VIAVI") notes the announcement made by Keysight Technologies, Inc. ("Keysight") and Spirent Communications plc ("Spirent") on March 28, 2024, of a recommended cash acquisition of Spirent by Keysight.
VIAVI believes that its...
Policybazaar, India's leading online insurance marketplace, is witnessing a significant increase in non-resident Indians (NRIs) choosing term insurance from India via its platform. This surge is driven by the unparalleled ease, affordability and...
TRON Forum (Chair: Ken Sakamura, Professor Emeritus of the University of Tokyo) is pleased to announce that four microcontroller manufacturers, Infineon Technologies Japan K.K. (President & CEO: Ikuya Kawasaki), STMicroelectronics K.K. (Country...
Frost & Sullivan recently researched the data center colocation services industry and, based on its findings, recognizes STT GDC India with the 2023 Indian Company of the Year Award. STT GDC India is a pioneer data center solutions provider that...
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...